Objectives/Hypothesis: To describe surgical outcomes and radiographic features of olfactory groove meningiomas treated by excision through the subcranial approach. Special emphasis is placed on paranasal sinus and orbit involvement.
INTRODUCTION
Olfactory groove meningiomas (OGM) originate from the anterior cranial base, commonly at the cribriform plate of the ethmoid bone, planum sphenoidale, and the frontospenoidal suture. Overall, they account for approximately 8% to 13% of the total of intracranial meningiomas. 1 Surgery is the preferred method of treatment, with radiation being withheld for cases of recurrent disease or high grade lesions. 2 The extent of primary surgery is thought to be the critical determinant of long-term cure rates. 3 Over the past 3 decades, surgical trends have emerged that favor radical resection of OGM, including the dural attachment and any involved bone. This is tempered by the delicate adjacent anatomy, and despite efforts at complete resection the recurrence rates of OGM over 10-year follow-up periods have been as high as 41%. 4 Caudal extension into the paranasal sinuses is thought to be an important component in the pathogenesis of recurrent OGM. 5 However, there is some disagreement if sinus invasion should dictate the surgical approach, particularly in treatment of primary disease. Some groups have postulated that bulky sinonasal extension in OGM is rare, and therefore is treatable with standard craniotomies. 1 Other institutions have found somewhat higher rates of sinus invasion, 6 and advocate use of modified craniotomies such as the subcranial approach for these cases. 7 Orbit invasion has also been described, 8 and when present will alter the planned approach. In the case of an OGM involving the sinuses and/or the orbit, radical resection entails resection of the involved portions of these bony structures. The creation of a communicating defect between the intracranial space and the sinonasal cavity may increase the associated risk of postoperative cerebrospinal fluid (CSF) leakage. Granted that entrance into the sinuses may be necessary for radical resection, expertise in reconstruction of skull base defects involving the sinonasal cavity is an important facet of treatment.
We present a case series of 19 patients with OGM treated via the subcranial approach. Special focus was given to the sinonasal manifestation and ophthalmologic outcomes following surgery. Our goal was to demonstrate that a multidisciplinary approach is most effective for treatment of OGM, particularly with respect to managing tumors that invade the sinuses and abut the optic apparatus.
MATERIALS AND METHODS
This retrospective study was based on a review of the hospital and outpatient clinical records of a consecutive series of patients who underwent excision of OGM via the subcranial/ transglabellar approach between December 1995 and November 2009. Patient and procedure data recorded for analysis included age, gender, comorbidity, prior surgery, prior radiation, prior chemotherapy, reconstruction type, tumor histology, and surgical margins based on final pathology. Comorbidity was defined by the Diagnosis Related Group codes for fiscal year 2010. For all lesions, the presence of paranasal sinus, orbit, or brain invasion was determined based on review of imaging, operative notes, and pathology reports.
The transglabellar/subcranial technique has been described in detail previously. 9 Briefly, wide exposure is achieved through a coronal approach, with careful preservation of a pericranial flap perfused by the supraorbital vessels ( Fig. 1 ). A frontal craniotomy is then made. Subperiosteal dissection is carried down inferiorly to completely free the superior orbit and nasal root for removal of the glabellar bar. The anterior ethmoid arteries are ligated and divided. Vertical osteotomies are made just medial to the supraorbital notch/foramen through the superior orbital rim. Osteotomies are then carried medially along the anterior cranial fossa floor, staying anterior to the crista galli. These are continued anteriorly, inferiorly, and obliquely across the medial orbital roof and down into the nasal bones, such that they pass anterior to the anterior lacrimal crest on each side. Final osteotomies are created along the nasal bones transversely, taking care to leave approximately 3 mm of nasal bone distally to support the upper lateral cartilages. A sharply curved osteotome is used to separate the bony nasal septum from the supraorbital bar. Although small modifications are made depending on tumor extent, the approach consistently provides generous in-line access to the anterior cranial base while minimizing or eliminating the need for frontal lobe retraction. The neurosurgery team performs the extirpation, usually with microdissection of tumor adjacent to the optic nerves, optic chiasm, or frontal lobe. Reconstruction is performed with a pericranial flap or with a free flap for previously irradiated patients.
Complications were classified as perioperative if they occurred within 30 days of the surgical procedure. These were divided into major and minor subcategories. Major complications were predefined as those associated with mortality, reoperation, procedural intervention (i.e., delayed lumbar drain), and/or permanent morbidity. Minor complications were those that were not associated with any permanent treatment or permanent morbidity. Additional postoperative data included surgical margins based on final pathology reported as Simpson resection grade. Assessment of visual acuity was performed in the outpatient clinic and documented by the neurosurgery, otolaryngology, or ophthalmology services.
The Kaplan-Meier method was used to estimate overall and disease-free survival. Survival estimates were generated on SPSS for Windows, version 11.01 (SPSS, Inc., Chicago, IL). The study was approved by our university's institutional review board.
RESULTS
Clinical presentation, treatment history, preoperative radiographic tumor size, and paranasal sinus involvement is listed for each patient in Table I . There was a high rate of paranasal sinus involvement in this series, with 14 of 19 patients (73.7%) having tumors that extended into the paranasal sinuses, with the ethmoid sinus being the most frequently involved subsite. There were nine recurrent tumors in the series, and prior therapy included surgery and/or radiation. There were three malignant tumors (World Health Organization [WHO] grade III). A representative preoperative magnetic resonance imaging sequence is presented in Figure 2 . This demonstrates a recurrent tumor with an extensive and infiltrative pattern of recurrence along the skull base, involving the ethmoid sinuses as well as the orbit. During the perioperative period, the most common intracranial complication was delayed CSF rhinorrhea (Table II) . Ten patients of the 19 experienced a perioperative complication, with seven patients (36.8%) experiencing a major complication. There were no perioperative mortalities.
The Kaplan-Meier method was used to estimate overall survival ( Fig. 3) as well as disease-free survival (Fig. 4) . The estimated mean for overall survival was 121.45 months (95% confidence interval [CI], 93.23-149.66) and the estimated mean for disease-free survival was 93.03 months (95% CI, 60.88-125.18). Table III highlights additional longterm clinical outcomes. Notably, of the 19 total patients in this series, 15 had preoperative tumor involvement of either the orbit or the optic nerve. Of these, three patients had long-term postoperative diplopia. One patient suffered an abducens nerve palsy after surgery. The other two patients had extensive orbital spread of meningioma that required dissection of tumor near the attachment of the extraocular muscles. No patient experienced permanent decline in visual acuity compared to preoperative visual exam. 
DISCUSSION
The caudal extension of OGM into the paranasal sinuses is a matter of some debate, both in terms of its frequency and its significance for surgical planning. One of the earliest estimates of this frequency stated that approximately 15% of OGM invade the ethmoid sinuses. 10 Nakamura et al. recently published a large series on OGM; they noted a 19.5% rate of paranasal sinus involvement. 1 The authors qualify this by stating that it is rare for OGM to have a predominant burden of disease in the sinuses. On the other hand, another recent series reported sinonasal extension in 26.3% of cases of OGM. 6 Several authors have highlighted the importance of paranasal sinus extension in the pathogenesis of OGM, particularly in recurrent cases. 5, 6 The high rate of sinonasal involvement in this series likely reflects both the large number of recurrent tumors, as well as the influence of a referral bias to our multidisciplinary skull base team. Meningioma in the sinonasal cavity usually represents secondary extension of the tumor through the anterior skull base. Primary extradural meningiomas are rare. 2 OGMs have a predilection for bony invasion of the cribriform plate and planum sphenoidale. The hyperostosis that often characterizes these tumors is thought to be a byproduct of tumor microinvasion rather than a reactive inflammatory process from the adjacent tumor. 11 It is thought that insufficient resection of unrecognized bone invasion may lead to higher rates of recurrence. 5 Reoperation is certainly more challenging, and often entails delicate decompression of the optic nerve in an area with poor tissue planes. 6 Recurrence rates have been reported as high as 41% in large series with 10-year follow-up. 4 Lower-grade resections have been found to be a significant predictor of recurrence. 3 Surgical trends have therefore shifted in favor of more aggressive resection. 5, 6 The complexity of the anterior skull base poses obvious challenges to achieving radical resection. Given that higher rates of bony invasion have been demonstrated in recurrent tumors, 12 excision of involved bone will by definition create a large cranial floor defect that freely communicates with the sinonasal cavity. In our opinion, this argues for multidisciplinary collaboration between otolaryngology and neurosurgery to allow for generous exposure, excision, and reconstruction of complex defects to minimize morbidity.
As there is no consensus regarding the best approach to OGM resection, debate over the merits and drawbacks of different surgical approaches to tumors of the anterior cranial base is ongoing. Comparisons of the indications, advantages, and disadvantages of various approaches have been detailed elsewhere. 6, 13, 14 Tables IV and V provide a broad comparison of surgical approaches, tumor characteristics, and outcomes of several OGM series described in the literature. The present series has a relatively high number of recurrent tumors, a high frequency of paranasal sinus invasion, and also includes atypical and anaplastic histologic subtypes.
With specific regard to visual outcomes, Gazzeri et al. report impressive results and low morbidity using the bifrontal approach. 15 The large average tumor size and longstanding nature of the preoperative visual deficits make these successes yet more impressive. In that series, all tumors were WHO grade I, arose de novo, and only one (2.8%) demonstrated paranasal sinus invasion. Tumors with more extensive inferior spread may not be as amenable to bifrontal resection. Paranasal sinus extension was noted in 30.4% of tumors undergoing bifrontal resection in the Nakamura series, and 22.9% of those in the Spektor series. 1, 6 In both series, all mortalities occurred in patients who underwent a bifrontal approach. Nakamura et al. ascribe these mortalities to brain edema consequent to the bifrontal approach and the large tumors resected with this approach.
The subcranial approach has several advantages in the treatment of OGM that merit discussion. It offers excellent access to the frontal, ethmoid, and sphenoid sinuses should tumor extend to these locations. Access to the orbit is generous as well, and ligation of the anterior ethmoid artery will, in theory, decrease bleeding during tumor excision as this is thought to be a key irrigating vessel for OGM. 2 The long-term vision results presented above suggest that this approach offers an excellent route to safely address intraorbital disease while also enabling wide exposure for effective microdissection of tumor off of the optic nerve and chiasm. Three patients had postoperative diplopia that was worsened after surgery. Of these, one patient suffered an abducens nerve injury during removal of the tumor and two patients had extensive intraorbital disease that necessitated intraorbital dissection along the attachment areas of the extraocular muscles. One patient had preoperative blindness in the affected eye, which did not improve following tumor excision. Overall, preservation of preoperative visual acuity was excellent, which is a credit to effective microdissection following good exposure. The overall survival in this series is expectedly high given that OGM may exhibit an indolent growth pattern. During the period of study, three tumors demonstrated clinical or radiographic evidence of recurrence. It should be noted, however, that this series includes one atypical (WHO grade II) and three malignant (WHO grade III) lesions. In addition, nine tumors were recurrences, with four of these having undergone prior radiotherapy in addition to prior surgery. Some recent case series have excluded high grade lesions, 1 and therefore one must bear this in mind when comparing shortand long-term outcomes. Furthermore, the high rate of paranasal sinus extension reflects tumor spread that was fairly extensive. In our opinion, this attests to the effectiveness of the subcranial approach in these cases.
One of the drawbacks of the subcranial approach that has been discussed in the context of OGM is that it is a time-consuming technique in relation to other commonly performed craniotomies (pterional, subfrontal, and bifrontal). 6 This is a valid criticism, as our average case duration was just under 13 hours. However, many of these cases required extensive microdissection along the optic apparatus, and this would be necessary regardless of the approach selected. Another concern with the subcranial approach is that removal of the frontal (glabellar) bar may result in long-term contour defects. Of the 19 cases of OGM treated, five patients underwent follow-up surgery that involved a revision of the initial reconstruction. Two patients underwent free flap revisions (one was performed on the harvest site), one patient underwent a cranioplasty for a contour defect, and two patients underwent washout procedures after developing osteomyelitis of the bone flap. The patients with bone flap osteomyelitis all had undergone adjuvant radiotherapy for either recurrent or high-grade (WHO III) disease. Osteomyelitis ensued after completion of the adjuvant treatment. Whether or not this is a widespread problem in patients undergoing radiotherapy following open skull base surgery is a question that merits study in a larger series. A third potential drawback of the subcranial approach is that the rates of CSF leak may be higher given the wide exposure of the cranial base. Indeed, given the trend toward radical resection of OGM, the rate of postoperative CSF leak is an important outcome for analysis in any series. The CSF leak rate reported here (15.8%) is similar to comparable series, which employed a variety of standard craniotomies. 6 Over the past decade, the applications of skull base endoscopic surgery have steadily expanded. 16 Possible technical advantages include early tumor devascularization, direct tumor access without brain retraction or exposure, and minimal manipulation of neurovascular structures including the optic nerve. [17] [18] [19] [20] Secondary advantages relate primarily to the fact that the technique is minimally invasive, with the potential for shorter hospital stays, decreased postoperative pain, and improved cosmesis. [20] [21] [22] In a recent study, Gardner et al. describe a series of 35 anterior cranial base meningiomas removed by the endoscopic endonasal approach. 17 Complete resection was achieved in 83% of cases intended for complete resection and in 67% of all OGM cases. Impressively, they report improved visual outcomes in all patients presenting with visual symptoms. The authors attribute this success to the endoscopic technique, as it affords both minimal manipulation of the optic nerve as well as microdissection of tumor off a compressed, ischemic optic nerve that is displaced superiorly, as is generally the case with tuburculum sellae meningiomas. 17 Indeed, endoscopic surgery has yielded excellent visual outcomes in tuburculum sellae meningiomas. 23 OGMs, however, tend to displace the optic nerve inferiorly and posteriorly. 6, 13, 24 Gardner et al. note that in such cases visual improvement is likely the result of simple decompression, even with incomplete resection.
The most commonly cited criticism of the endoscopic approach is the high rate of CSF leak. The previously discussed series reports a CSF leak rate of 40%. 17 Incomplete visualization of the floor of the anterior and cranial fossa and of minor dural defects may contribute to this high leak rate. 25 It is important to note that in the Gardner series, no patients experiencing CSF leak required reoperation, and there were no reported cases of bacterial meningitis. Furthermore, recent innovations in pedicled nasoseptal flap reconstruction have decreased CSF leak rates significantly. 26, 27 A comparative analysis of the merits of endoscopic OGM removal versus the subcranial approach is somewhat handicapped by the inclusion criteria of each study. The possible contraindications to endoscopic extirpation listed in prior studies are numerous: large tumor size, tumor consistency, encasement of vascular structures, lateral extension, lateral dural attachment, brain invasion, frontal sinus extension, and the presence of long dural tails. 14, 18, 20 At the heart of the matter is the notion that recurrence rates may prove to be higher with endoscopic approaches, as all suspicious underlying bone should be resected (Simpson grade I resection), which is presumably facilitated by open exposure. 25 This claim, though intuitive, is not definitively substantiated by available data. Long-term follow-up data following endoscopic resection of OGM will help to more precisely define the indications for endoscopic removal. It remains to be seen if recurrent tumors, tumors with more aggressive histology, and lesions involving the optic apparatus are all addressed effectively via endoscopic approaches. This data will hopefully be useful for such future comparisons. Currently, proponents of the endoscopic approach admit that it is indicated in carefully selected patients, and caution that the learning curve is steep. 17, 28 Despite the restrictive indications for endoscopic resection of OGM, it remains an evolving field that holds great promise for the future.
CONCLUSION
OGM is a skull base neoplasm with significant rates of bony infiltration and subsequent spread to the paranasal sinuses. The subcranial approach offers excellent access for resection of OGM, particularly in cases where tumor extends to the paranasal sinus and orbit. Despite a significant number of recurrent or aggressive histologic subtypes, the surgical outcomes over the period of follow-up were comparable to other recent series. Vision preservation was a notable and important benefit. As a whole, this underscores the value of the otolaryngologist-head and neck surgeon in the multidisciplinary management of these tumors.
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